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Identification of genes encoding squalestatin S1
biosynthesis and in vitro production of new
squalestatin analogues†
B. Bonsch,a V. Belt,a C. Bartel,a N. Duensing,a M. Koziol,b C. M. Lazarus,b
A. M. Bailey,b T. J. Simpsonc and R. J. Cox*ac
A gene cluster responsible for the biosynthesis of squalestatin S1
(SQS1, 1) was identified by full genome sequencing of two SQS1-
producing ascomycetes: Phoma sp. C2932 and unidentified fungus
MF5453. A transformation protocol was established and a sub-
sequent knockout of one PKS gene from the cluster led to loss
of SQS1 production and enhanced concentration of an SQS1
precursor. An acyltransferase gene from the cluster was expressed
in E. coli and the expressed protein MfM4 shown to be responsible
for loading acyl groups from CoA onto the squalestatin core as the
final step of biosynthesis. MfM4 appears to have a broad substrate
selectivity for its acyl CoA substrate, allowing the in vitro synthesis
of novel squalestatins.
Squalestatin S1 (SQS1, also known as zaragozic acid A) 1 was
independently discovered by Glaxo1 and Merck2 in the early
1990s as a novel lead compound for the treatment of hyper-
cholesterolemia by targeting squalene synthase (SS). SQS1 1 and
related compounds are potent pM inhibitors of mammalian and
fungal SS.3 SQS1 1 correspondingly shows broad spectrum
antifungal properties and lowers the blood cholesterol level of
rhesus-monkeys in vivo.4
Numerous diﬀerent squalestatins have been isolated from
more than ten taxa of filamentous fungi, mostly varying in
the attached 1-alkyl and 6-O-acyl side chains.5 However the
class is distinguished by the highly functionalised 4,8-dioxa-
bicyclo[3.2.1]octane core. Feeding experiments using labelled
precursors identified the origin of the heavy atoms of 1 (Fig. 1).6,7
The biosynthesis involves the production of two polyketides: a
hexaketide initiated by benzoate; and a tetraketide produced
by a highly reducing fungal polyketide synthase (hrPKS).8 The
remaining carbon atoms are derived from a citric acid cycle
intermediate (such as oxaloacetate).
We previously reported the isolation and sequence of the gene
(phpks1) encoding squalestatin tetraketide synthase (SQTKS).9
Expression of phpks1 in Aspergillus oryzae resulted in the isolation
of the tetraketide chain of SQS1 from liquid culture.8 Since
no other molecular information is available for squalestatin
biosynthesis, we undertook to generate more information via
full genome sequencing.
Two fungal strains have been previously identified as pro-
ducers of 1: Phoma sp. C2932 (Glaxo); and unidentified strain
MF5453 (Merck). Initial sequencing of internal transcribed
spacer (ITS) sequences obtained by PCR showed the two strains
to be closely related (see ESI†).
Genomic DNA from both organisms was sequenced and
assembled to give two high quality draft genomes (see ESI†).
A putative SQS1 gene cluster was identified in both organisms
by comparison of the assembled sequences to the previously
characterised phpks1 gene (Fig. 2).10
In order to more clearly link the clusters with the biosynthesis
of 1, and delineate the boundaries of the cotranscribed genes,
MF5453 was grown under producing and non-producing condi-
tions (see ESI†). mRNA prepared under these conditions was
Fig. 1 Origin of heavy atoms in SQS1 1.
Fig. 2 SQS1 genomic region from A, Phoma sp. C2932 and B, MF5453: L,
left hand side of pks1; M, between pks1 and pks2; R, right hand side of pks2.
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used for quantitative reverse transcription polymerase chain
reaction (qRT-PCR). The expression level of all genes from
mfpks1 to mfR6 was strongly linked to the production of SQS1
1 in the culture medium (Fig. 3), being between 102 and 105
fold more highly expressed under producing conditions. This
suggests that the pks1 and R6 genes form the boundaries of a
cotranscribed region.
A comparison of the SQS1 clusters from MF5453 and C2932
shows a highly similar composition of genes and a high identity/
similarity (74–93%/82–97%) between proteins with the same
predicted activity (see ESI†).11 A search of the NCBI database
using sequences from these clusters revealed a third putative
squalestatin cluster in Dothistroma septosporum. Comparisons
(see ESI†) show that all genes between pks1 and R6 are conserved
in all 3 clusters, suggesting these may be the limits of the
biosynthetic gene cluster.
Both phenylalanine and benzoic acid are known6 precursors
of 1 and so it is unsurprising that the cluster also contains
genes potentially involved in benzoate production: phenyl-
alanine ammonia lysase (PAL), encoded by M7, catalyses the
first step in the degradation of phenylalanine (Scheme 3). In
other microbial and plant systems12 cinnamate is hydrated,
oxidised and then subject to a retro-Claisen reaction during the
synthesis of benzoyl CoA, and the NADP-dependent dehydro-
genase M3 may also be involved in this.
The cluster contains two PKS encoding genes: both PKS
belong to the highly reducing class.13 The tetraketide synthase,
has already been shown to be responsible for the biosynthesis
of the tetraketide sidechain of SQS1 1.8,14 The other is therefore
likely to encode squalestatin hexaketide synthase (SQHKS).
The hexaketide main chain is initiated by benzoate (Scheme 3,
vide infra) which is an unusual starter unit for hrPKS and
comparison of the sequences of the putative hexaketide synthase
AT domains with AT domain from hrPKS which select acetate
as the starter unit, show consistent substitutions in residues
adjacent to the AT active site (see ESI†). The cluster also contains
a gene encoding a citrate synthase-like protein (encoded by R3)
linking the biosynthetic pathway to those recently reported to be
involved in maleidride biosynthesis in fungi15,16 and presumably
involved in linking the hexaketide to the oxaloacetate moiety
(Scheme 3). The biosynthesis of 1 requires several oxidative steps
(Scheme 3). Based on sequence comparisons alone (e.g. BLAST)
no encoded protein shows significant homology to known
oxygenases. However M1 shows modest structural homology
(e.g. PHYRE2)17 to copper dependent peptidylglycine monooxy-
genases and R1 and R2 show some structural homology to non-
heme iron dependent enzymes.
Two putative acyltransferases (AT) are encoded in the cluster.
One, encoded by mfM4, shows high sequence homology (20%
identity, 37% similarity) to tricothocene-3-O-acetyltransferase
(Tri101) from Fusarium species with which it shares the key
active site residues H163 and D167.18 Residues involved in CoA
binding identified from the crystal structure of Tri101,18 are also
conserved in MfM4, including L-282, T-298, D-300, and L-425
(see ESI†). The other AT, encoded by R4, shows low homology to
the membrane-spanning acyltransferase-3 superfamily including
proteins such as OaC from Shigella flexneri which encodes an
O-acetyl transferase involved in serotype development (see ESI†).19
Finally, in support of the identification of the clusters as being
responsible for 1 production, all three contain a gene encoding
a putative SS (R6), presumably encoding a resistance protein.
The genomes of Phoma C2932, MF5453 and D. septosporum
also contain housekeeping SS genes. Multiple alignment of
these sequences with human SS,20 shows that some identified
substrate binding residues of human SS are substituted
(e.g. L186V and C299V) in the resistance proteins but not the
housekeeping proteins suggesting a likely mechanism for self-
resistance (see ESI†).
Neither Phoma sp. C2932 or MF5453 have been reported to
undergo genetic transformation. A PEG based transformation
protocol using protoplasts for MF5453 and C2932 was therefore
established, based on hygromycin selection with an auxiliary
egfpmarker gene. Establishment of the transformation protocol
was confirmed by observation of green fluorescent mycelia of
hygromycin-resistant MF5453 transformants (see ESI†).
The phpks1 gene in MF5453 was then knocked out21 which
resulted in the creation of ten hygromycin resistant transformants.
Three of these were analysed by PCR and shown to have incorpo-
rated the hygromycin resistance gene and the expected lesion in
phpks1. The LC-MS traces of one MF5453 knockout transformant,
grown under 1-producing conditions, were compared to the wild
type (WT) strain and diﬀerent standards (Fig. 4).
Partial hydrolysis of SQS1 1 with aqueous potassium hydroxide
gave a mixture of the core metabolite 2, the two mono-acylated
cores 3 (loss of 6-O-tetraketide) and 4 (loss of 12-O-acetate) and
unreacted starting material 1 (Scheme 1). All compounds were
purified by mass-directed reverse-phase chromatography and fully
characterised by NMR spectroscopy (see ESI†). Full hydrolysis
(acidic conditions) gave the tetraketide 5 in quantitative yield. In
the extract of WT MF5453, grown under producing conditions,
SQS1 1 is the major product, but traces of compounds 2, 3 and 4
are observable (Fig. 4C). The SQTKS knockout mutant of MF5453
shows no SQS1 1 production but very high titres of 3, in which the
tetraketide is missing (Fig. 4D). Compound 4 which would require
an active SQTKS was also not evident in the extract.
These results show that transfer of the tetraketide to 3
is likely to be the final step of biosynthesis. As shown above,
the gene cluster contains two genes encoding putative ATs
Fig. 3 Relative gene expression levels of selected genes in the SQS1
cluster of MF5453 under producing (red) and non-producing (blue)
fermentation conditions measured using qRT-PCR, average of four non-
producing and five producing biological replicates.
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(mfM4 and mfR4). The expected intronless sequence of mfM4
was expressed and purified from E. coli (see ESI†). The mfR4
gene was also expressed. However extensive expression trials
did not give adequate soluble protein for further study, even
using an E. coli optimised sequence.
Squalestatin tetraketide pantetheine 6 and CoA 7 were
synthesised by literature procedures and purified by mass-
directed HPLC. In vitro assays were set up in which various
possible substrates (2, 3 or 4) were incubated in buﬀer in the
presence of MfM4 and various acyl groups (6, 7) and acetyl,
hexanoyl and octanoyl CoAs and the reactions were monitored
by LCMS (Scheme 2). No evidence could be obtained for the
transfer of the tetraketide from pantetheine to any possible
acceptor. However, MfM4 does transfer acetate, hexanoate and
octanoate from their corresponding CoA thiolesters to 3 (Fig. 5).
When the tetraketide CoA 7 was used as a substrate for the
reaction with 3 and MfM4, SQS1 1 was synthesised showing
that transfer occurs specifically to the 6-hydroxyl of 3. Com-
pounds 8–10 are new squalestatin analogues synthesised
in vitro for the first time. Acyl groups were not transferred to
2 or 4 by MfM4 showing that the 12-O-acetate must be attached
earlier during biosynthesis, and further confirming that the
6-hydroxyl is the target for acylation.
Thus our results reveal the biosynthetic gene cluster for the
squalestatins for the first time. The cluster encodes two highly-
reducing PKS, similar to those known for lovastatin bio-
synthesis. In the case of the lovastatins a diketide is transferred
to a nonaketide as an ester-bound sidechain. This occurs via a
specific acyl transferase LovD,22 which appears to unload the
complete diketide from its PKS onto itself before then passing
it directly to the hexaketide hydroxyl so there is no enzyme-free
diketide intermediate.
In the case of squalestatins the mechanism is diﬀerent: the
tetraketide synthase appears to transfer its product to CoA as an
enzyme-free intermediate. The AT MfM4 then transfers the acyl
group selectively to the 6-OH of 3. MfM4 has a broad substrate
selectivity in terms of its CoA substrate, transferring chains
from 2 to 10 carbons. This explains the wide range of known
squalestatins with various acyl groups at O-6, which presum-
ably arise by use of the prevailing CoA thiolester pool in various
host organisms.5 Formation of the tetraketide CoA from 5 may
be catalysed by the M9 CoA ligase, but the mechanism of
release of 5 and the hexaketide from their respective PKS
remains unknown, although the cluster encodes a potential
esterase (M8) and a possible hydrolase (M10) which could be
involved in these processes.
Our experiments open up new opportunities for further
investigating squalestatin biosynthesis. For example formation
of the 4,8-dioxa-bicyclo[3.2.1]octane core involves linkage of
the hexaketide to oxaloacetate, presumably by the R3 citrate
synthase, but the timing and precise substrates of this step
are unknown. However, comparison to the fungal metabolite
viridiofungin A 1123 suggests this step occurs early during
biosynthesis. The hexaketide and oxaloacetate require several
Fig. 4 ES total ion current (TIC) LCMS traces of SQS1 derivatives and
MF5453 culture broth extracts: A, SQS1 1 standard; B, hydrolysis products of
SQS1 under acidic catalysis; C, wild type extract from a 6 day old MF5453
liquid culture; D, extract of a phpks1-Knockout transformant of MF5453.
Scheme 1 Hydrolysis of SQS1. The main products 2, 3, 4 and 5 were
purified by LCMS and identified by NMR spectroscopy.
Scheme 2 In vitro preparation of squalestatin S1 and analogues.
(i) Pantetheine dimethylacetal, DMAP, EDCI, CH2Cl2; (ii) 10% TFA in CH2Cl2,
20 min; (iii) CDI, CoASH.
Fig. 5 ES LCMS traces showing the transfer of acyl groups from CoA to
3: A, standard 3 from hydrolysis of SQS1 1 (TIC); in vitro reaction product of
AT1 with B, acetyl CoA + 3 (TIC); C, hexanoyl CoA + 3 (TIC); D, octanoyl
CoA + 3 (TIC); E, tetraketide CoA 7 + 3 (EIC).
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oxidative steps, but the cluster encodes no proteins with strong
sequence homology to known oxygenases. However three of the
encoded proteins show some structural homology to known
oxygenase proteins (i.e.M1, R1 and R2) and the activity of M5 is
unknown, so it is possible that these may be new types of
multifunctional oxidases similar to LovA which catalyses two
oxidations during lovasatin biosynthesis.24 SQS1 1 is one of very
few fungal polyketides with a benzoate starter unit and further
investigations are required to determine the origin of this
selectivity.
Our present work thus focusses on in vitro and in vivo
explorations of the cluster to address these and other ques-
tions. Furthermore, the results presented here show that new
squalestatins can be engineered, and further work to alter the
skeleton and substitution pattern of 1 is currently underway.
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